1-2 of 2
Matthew A Lunning
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Vein-to-vein Time in Patients With R/R LBCL Treated With Axicabtagene Ciloleucel

Frederick L Locke, Tanya Siddiqi, Caron A. Jacobson, Sarah Nikiforow, Sairah Ahmed, David B Miklos, Yi Lin, Matthew A Lunning, Brian T. Hill, Armin Ghobadi, Zhen-Huan Hu, Michael T. Hemmer, Michael J Zoratti, Suresh Vunnum, Jonathan Tsang, Clare Spooner, Harry Smith, Christine Fu, Anik R Patel, Harry Miao, Shilpa A. Shahani, Debbie L. Mirjah, Hairong Xu, Marcelo C. Pasquini
Journal: Blood Advances
Blood Adv bloodadvances.2024013656.
https://doi.org/10.1182/bloodadvances.2024013656
Published: 2025
Includes: Supplemental data
Journal Articles

Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 study

Clinical Trials & Observations
Juan P. Alderuccio, Weiyun Z. Ai, John Radford, Melhem Solh, Kirit M. Ardeshna, Matthew A. Lunning, Brian T. Hess, Pier L. Zinzani, Anastasios Stathis, Carmelo Carlo-Stella, Mehdi Hamadani, Brad S. Kahl, David Ungar, Turk Kilavuz, Eric Yu, Yajuan Qin, Paolo F. Caimi
Journal: Blood Advances
Blood Adv (2022) 6 (16): 4736–4739.
https://doi.org/10.1182/bloodadvances.2022007782
Published: 2022